Sutter Health, UPMC, and DNAnexus Initiate Collaboration to Improve Personalized Treatments for People with Multiple Sclerosis
First large-scale clinico-genomic MS study by leading healthcare system to advance research by building multi-dimensional datasets from a diverse population of more than 3,000 patients April 15, 2019 08:00 AM Eastern Daylight Time MOUNTAIN VIEW, Calif. & SACRAMENTO, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., and the not-for-profit Sutter Health network today announced the first large-scale clinico-genomic multiple sclerosis (MS) research... Read more